Harvard Bioscience (HBIO) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$1.2 million.
- Harvard Bioscience's Profit After Tax rose 7436.48% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.8 million, marking a year-over-year decrease of 27802.82%. This contributed to the annual value of -$12.4 million for FY2024, which is 26325.04% down from last year.
- Per Harvard Bioscience's latest filing, its Profit After Tax stood at -$1.2 million for Q3 2025, which was up 7436.48% from -$2.3 million recorded in Q2 2025.
- In the past 5 years, Harvard Bioscience's Profit After Tax registered a high of $2.4 million during Q2 2022, and its lowest value of -$50.3 million during Q1 2025.
- Its 5-year average for Profit After Tax is -$4.2 million, with a median of -$1.2 million in 2023.
- Over the last 5 years, Harvard Bioscience's Profit After Tax had its largest YoY gain of 69390.24% in 2022, and its largest YoY loss of 190294.12% in 2022.
- Over the past 5 years, Harvard Bioscience's Profit After Tax (Quarter) stood at $961000.0 in 2021, then plummeted by 273.36% to -$1.7 million in 2022, then fell by 9.12% to -$1.8 million in 2023, then skyrocketed by 100.99% to $18000.0 in 2024, then tumbled by 6938.89% to -$1.2 million in 2025.
- Its last three reported values are -$1.2 million in Q3 2025, -$2.3 million for Q2 2025, and -$50.3 million during Q1 2025.